Introduction
Cancer is a relevant public health problem because of its increased incidence, morbidity and mortality. According to the World Health Organization (WHO), approximately 80% of the 20 million new cases expected for 2015 would occur in developing countries [1] .
Among the various types of neoplasia, breast cancer is the one that most affects women every year, being responsible for 23% (1380.000) of all new cases of cancer and 14% (458,400) of all deaths due to cancer [2, 3] , with 57,950 new cases being projected for 2016/2017 in Brazil [4] . The nutritional status and dietary intake of the patient plays a key role both regarding the risk factors for breast cancer [5, 6] and the results of its treatment [7] .
Obesity is a risk factor for the development of breast cancer in women, especially after menopause and has an adverse prognostic effect on the survival of these women. Adipose tissue should be considered to be a metabolically active endocrine tissue and excess body fat appears to influence the development and progression of breast cancer due to increased estrogen synthesis, insulin resistance and activation of inflammatory pathways [8, 9] . Studies have suggested associations between body fat, body mass index (BMI) and waist circumference (WC) as risk factors for the development of breast cancer [4, 10] . In addition, the stress caused by the diagnosis and chemotherapeutic treatment of breast cancer has been related to weight gain due to changes in life style characterized by physical inactivity and inappropriate eating habits [11, 12] .
These metabolic changes also lead to the development of metabolic syndrome (MS) [13] , a complex disorder consisting of a set of cardiovascular risk factors and an increased risk of breast cancer recurrence [14] . The main components of MS are systemic arterial hypertension (SAH), insulin resistance, obesity and dyslipidemia [15] and several studies have demonstrated that the increased incidence of breast cancer over the last decades has been accompanied by an increased frequency of MS [16, 17] .
In Brazil, studies show high prevalence rates of MS in the population. One of these population-based studies, with adults, found a prevalence of 29.8% (CI95% 28e32) of SM [18] . Another study, carried out with elderly found that the overall prevalence of MS was 58.6% (95% CI 49.8e67.1), and for men this percentage was (95% CI: 41.3e69.5) and for women 60.5% (CI95% 49.1e71.2) [19] .
In view of this, it is possible to observe that the prevalence of MS in women with breast cancer follow this tendency. A study carried out with this public shows that MS was present in 50% of the surviving women, when compared with the control group that found 37.5% of participants with MS. In this study, the most frequent diagnostic criteria were: abdominal obesity (62.5%) and dyslipidemia (45.2%) [20] . Another study, also carried out with women with breast cancer, found that 69.2% of postmenopausal women had MS and 53.8% had advanced stages of cancer, demonstrating that MS could influence the worsening of cancer prognoses of breast [4] .
Thus, knowledge about the nutritional and metabolic profile of breast cancer patients represents an important measure for the development of multiprofessional actions aiming at the elaboration of strategies directed at the various phases of the disease and its treatment [21] .
Early detection of MS in women during breast cancer treatment is very important, since such comorbidity raises cardiovascular risk, is related to prior prognosis of cancer, increases the risk of death and causes a negative impact on the quality of life of women [22] .
On this basis, considering the lack of studies in the literature evaluating the possible association of breast cancer with the metabolic syndrome in Brazil, and none of them compare different diagnostic criteria, this present study aimed to assess the nutritional and metabolic profile of women with breast cancer and its possible association with MS according to the criteria of the WHO [23] , of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) [24] and of the International Diabetes Federation (IDF) [25] . The study was conducted on women with breast cancer seen at a rehabilitation nucleus located in the interior of the state of São Paulo.
Methods

Subjects
This was an observational, descriptive cross-sectional study conducted from September to November 2015 at a rehabilitation nucleus for women with breast cancer called Nucleus of Teaching, Research and Assistance in the Rehabilitation of Mastectomizados located in the School of Nursing of Ribeirao Preto (EERP) of the University of Sao Paulo (USP), in the city Ribeirao Preto, Sao Paulo, Brazil. This rehabilitation center offers comprehensive assistance to women affected by breast cancer, offering biopsychosocial support through a multiprofessional team consisting of nurses, physiotherapists, nutritionists and psychologists. The study was approved by the Research Ethics Committee of the institution (protocol no. CAEE: 41688915.3.0000.5393) and all subjects gave written informed consent to participate.
All women who participated in the activities of the rehabilitation nucleus from January to December 2014 (n ¼ 224) were considered for the study sample. Of these, 15 died and 65 were excluded because they did not satisfy the inclusion criteria of the study. Of the 144 women left, 77 were excluded for refusal to participate or for the impossibility of contact, with a final sample of 67 participants being left.
Inclusion criteria were: age of more than 18 years and being a participant in the rehabilitation nucleus who had been diagnosed and treated at the University Hospital, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo. Exclusion criteria were: advanced metastatic disease or absence of clinical conditions for participation; amputated or immobilized limbs; generalized edema and/or ascites, and presence of heart pacemaker, aneurysm clip or metal implants of any type (metal wires, plates or screws).
The anthropometric measurements obtained were weight, height, waist, hip, arm and calf circumference, and skin folds. Handgrip strength was also measured. All measurements were made in triplicate and the mean of the three values was used, except for handgrip strength. Weight was measured with a Welmy electromechanical digital scale for adults with a maximum capacity of 200 kg and 100 g divisions, calibrated by a qualified company before data collection. Height was measured with an anthropometric ruler coupled to the scale with 0.5 cm precision and with a maximum extension od 2 m. BMI was calculated as weight in kg divided by height squared in meters and the nutritional status of the patients was determined according to the criteria of the WHO [26] for adult patents and according to the criteria of the Pan-American Health Organization for elderly women [27] . The waist/ hip ratio (WHR) was calculated and the value of 0.85 was used to determine cardiovascular risk [26] .
The waist, hip, arm and calf circumferences were measured as recommended by Lohman et al. (1988) [23] . Tricipital, bicipital, subscapular and suprailiac skin folds were measured on the right body half of the patients and percent body fat (% BF) was estimated using the values adopted by Durmin and Womersley [28] and classified according to the values proposed by Lohman et al. (1992) [29] . The handgrip strength test was carried out using a Handgrip digital dynamometer mode CharderMG4800. A standardized position was used, with the subject sitting on a chair with a straight vertical back, with the elbow flexed 90 and the forearm in a neutral position and using the non-dominant hand [30] . The test was carried out in triplicate and the highest value obtained was recorded.
Body composition was assessed by bioelectrical impedance using the Biodynamics 450, analyzer with a current of 800 microamp eres and 50 kHz. For the exam, the subjects, wearing light clothing, lay in dorsal decubitus on a gurney with a pair of electrodes positioned on the foot and another on the hand, both on the side opposite to the surgery for breast cancer [31] . Obesity was classified according to the cut-off points for fat mass proposed by Lohman et al. (1992) [29] . The subjects were tested after at least 5 h of fast, having practiced no vigorous physical activity in the last 12 h, having urinated 30 min before the beginning of the test and having abstained from alcoholic or caffeine-containing beverages for 24 h before the exam.
A blood sample was collected by venipuncture from the arm contralateral to the breast surgery after a 12 h fast for the determination of fasting glycemia. The reference value was that recommended by the 2014e2015 Brazilian Directives for Diabetes which considers <100 mg/dL as normal, > 100 to <126 mg/dL as reduced glucose tolerance, and !126 mg/dL as diabetes mellitus [32] . The same blood sample was used to determine the lipid profile using as reference the values proposed by the 5 t h Brazilian Directive of Dyslipidemia and Prevention of Atherosclerosis, i.e.: total cholesterol <200 mg/dL, LDL-cholesterol < 160 mg/dL, HDLcholesterol ! 50 mg/dL, and triglycerides <150 mg/dL [33] .
Blood pressure (BP) was measured with an Omron (HEM-7200) instrument of the Omron 7000 line. The reference values for pressure levels were those established by the Brazilian society of Cardiology in the 6 t h Brazilian Directives of Hypertension (2010), which define BP ! 140/90 mmHg as arterial hypertension. The measurement was made in triplicate on the arm contralateral to the surgical procedure and the mean of the last two values was considered to be the real BP [33] .
MS is characterized by the association of several cardiovascular risk factors in the same individual and has been associated with an increased risk of breast cancer [34] , as well as with coronary disease, stroke and peripheral vascular disease [35] . The syndrome is defined by the presence of visceral or centripetal obesity associated with changes in BP, lipid profile and insulin metabolism. There are different criteria for the definition of MS, such as those of the WHO [23] , of the NCEP-ATP III) [24] , revised in 2004, and of the IDF [25] .
There is no consensus about the best definition of MS to be used and its diagnosis must include the presence of abdominal obesity as an essential condition, so this condition must be present plus 2 other criteria as defined, for example, by NCEP-ATP III, as shown in Table 1 .
Statistical analysis
A descriptive analysis was carried out, resulting in frequency tables for the qualitative variables. The Fisher exact test was used to determine the relationship between the qualitative or nominal variables, and the nonparametric Mann-Whitney and Kruskal-Wallis tests were used to determine the relationship between continuous and categorical measures. All analyses were carried out with the aid of the IBM SPSS 20 (Statistical Package for the Social Sciences) e Excel 2010 ® (Microsoft Office) software considering a bidirectional a of 0.05 and a 95% confidence interval.
Results
The sociodemographic characteristics of the sample under study were: age range, 32e85 years (mean ± SD: 58.8 ± 12.2 years), a higher proportion of women aged 51 to 50 years (37.3%), and a predominance of women living with a partner (55.2%) and who did not perform any remunerated activity (68.7%). Regarding life habits, most participants denied smoking (67.2%), reported no intake of alcoholic beverages (92.5%), and practiced mild physical activity, being classified as irregularly active (74.6%). Regarding clinical characteristics, women who underwent mastectomy (62.7%), axillary lymphadenectomy (83.6%), sentinel lymph node biopsy (55.2%) and did not undergo breast reconstruction (73,1%). As for the other treatment modalities, 74.6% underwent chemotherapy, 77.6% under hormone therapy and 11.9% under biological therapy. Regarding the presence of metastases or recurrence, 10.4% presented disease progression, as shown in Table 2 .
The parameters used for the classification of nutritional status revealed that most of the adult women (38.8%) had excess weight according to the BMI ranges proposed by the WHO for adults [26] , the same being observed for women older than 60 years, 23.8% of whom also showed excess weight [27] .
WC and WHR values were increased in 95.5% and 83.6% of the subjects, respectively. On the other hand, % fat mass obtained by bioelectrical impedance revealed that most subjects (53.7%) were normal, whereas the skin fold sum showed that 47.8% were overweight or obese. Analysis of phase angle using the 5 t h percentile as the cut-off point demonstrated that 81.8% of the women were in a normal situation, and the handgrip test also revealed that 74.6% were normal. Most women (91%) showed no impairment of nutritional status based on calf circumference (CC).
In summary, these data demonstrate the overweight characterization of this sample, evidenced also by high prevalence of excess weight (70.2% among adult women and 53.3% among elderly women) was observed among women with breast cancer, using the respective cutoff points for the BMI, considering pre obesity and obesity degrees according to the reference proposal for the age group, whereas malnutrition was present in a minority of subjects. These data are listed in Table 3 .
The biochemical analyses showed that only 12% of the patients had high cholesterol levels; 98.5% showed no changes in lowdensity lipoprotein-cholesterol (LDL-cholesterol); 86.6% had low high-density lipoprotein-cholesterol (HDL-cholesterol), and 25.4% had hypertriglyceridemia (TG).
High fasting glucose levels were detected in 44.8% of the patients and systolic and diastolic arterial pressure was elevated in 13.4% and 4.5% of the women, respectively (Table 4) . BMI, WC, arm circumference (AC) and fat-free mass (FFM) were negatively correlated with HDL and positively correlated with glucose (p < 0.05). In contrast, FFM was positively correlated with LDL, TG and glucose and negatively correlated with total cholesterol (TC) and HDL. TC, HDL, LDL. Other correlations are presented in Table 5 .
MS was present in 34.3%, 62.7% and 53.7% of the participants according to the definition of the WHO, IDF and NCEP, respectively. The agreement between the criteria used for the definition of MS was analyzed by determining the Kappa coefficient, and was considered to be moderate for WHO x IDF / K ¼ 0.48 (95% CI 0.30e0.66) and WHO x NCEP / K ¼ 0.56 (95% CI 0.37e0.74) and almost perfect for NCEP x IDF / K ¼ 0.82 (95% CI 0.69e0.95).
Twenty-three (34.3%), 42 (62.7%) and 36 (53.7%) patients had MS according to the criteria of the WHO, IDF and NCEP, respectively ( Fig. 1) .
Comparison of patients with and without MS revealed that, regardless of the criterion used to define the syndrome, there were statistically significant differences in WHR, BMI, WC and FFM, i.e., patients with MS had greater abdominal adiposity reflected by WC and WHR, higher BMI and FFM values, while the inverse was observed for HDL levels, which were significantly higher in subjects with MS. Also regardless of the criterion used, no significant differences in fat mass, phase angle, handgrip strength (contralateral and homolateral) or SAH duration were observed between subjects with and without MS.
Among the remaining factors analyzed in patients with and without MS, those showing statistically significant differences according to each criterion are listed below:
1. WHO: subjects with MS had significantly higher BMI, WC, skin fold sum, FFM and WHR values than subjects without MS. 2. IDF: according to this criterion, patients with MS were older (p < 0.001) than those without MS. In addition to more pronounced abdominal adiposity according to higher WC (p < 0.001) and WHR (p < 0.001) values, patients with MS also had a worse lipid profile characterized by higher TG (p ¼ 0.003) and lower HDL (p ¼ 0.03) values. 3. NCEP: according to this criterion, patients with MS were also older (p ¼ 0.001) than those without MS and had higher WC (p < 0.001), WHR (p < 0.001) and BMI (p < 0.001) than patients without MS. Table 6 presents additional information about the patients with and without MS.
Discussion
This present study aimed to assess the nutritional and metabolic profile of women with breast cancer and its possible association with MS according to 3 different criteria: WHO [23] , NCEP-ATP III [24] and IDF [25] . Among the main findings of this study are the high prevalence of excess weight (70.2% among adult women and 53.3% among elderly women), while the MS was detected in 34.3%, 62.7% and 53.7% of the participants according to the definition of the WHO, IDF and NCEP, respectively. The association of nutritional and metabolic status with the results is a source of concern for patients with breast cancer.
A prospective study conducted in Denmark on women with breast cancer revealed that women with a BMI of 30 kg/m 2 or higher had more advanced disease at the time of diagnosis compared to women with a BMI of less than 25 kg/m [2] . When the data were adjusted for the characteristics of the disease, the participants with a BMI of 30 kg/m 2 or more showed a significantly increased risk (46%) to develop metastases after 10 years and a 38% higher risk to die as a result of breast cancer after 30 years [36] . Cho [37] . Thus, it is extremely important to assess the nutritional status of women with breast cancer in a routine manner, with easy anthropometric measures such as BMI and WC being obtained as part of the treatment of this population. On the other hand, it should be pointed out that this high increase in BMI may impair the identification of possible nutritional deficiencies since the assessment of nutritional status is commonly neglected in women with breast cancer. Also, the presence of malnutrition and/or impairment of nutritional status should be investigated even in patients with excess body fat.
Body fat may increase at the expense of an important reduction of muscle mass despite an increase in BMI, a fact that may be related to worse results and a worse prognosis, a reduced quality of life and worse functionality [21] .
The prevalence of MS in different populations is strongly dependent on the criteria used for its definition and on regional characteristics [38] . Over the years, different directives have been proposed to define MS, such as those of the NCEP, the WHO, the IDF, of the American Association of Clinical Endocrinologists (AACE), and of the European Group for the Study of Insulin Resistance (EGIR). The first three of these have been more frequently employed and there still is no consensus about the best definition of MS. Regardless of the criterion adopted, previous studies have demonstrated a tendency to the detection of a high prevalence of MS among women with breast cancer, as reported by Bering et al. (2015) who detected a 41.9% prevalence in their patients with breast cancer [4] , whereas Capasso et al. (2011) detected a prevalence of about 30% in their own patients [39] .
The prevalence of MS observed in the present study was high, especially when the criteria of the IDF (62.7%) and NCEP (53.7%) were used. The lower performance of the WHO criterion (34.3%) for the identification of MS may be attributed to the anthropometric characteristics of the present patients. Indeed, about 95.5% of the participants had a WC value above the recommended cut-off point. This is a variable considered by the IDF and NCEP criteria, whereas the WHO considers the WHR and in this case this value fell to 83.6% of subjects with levels above the recommended ones, thus possibly interfering with the final classification of the participants. Another point to be considered is that the WHO recommends the inclusion of urinary albumin excretion (!20 mg) or the albumin/creatinine ratio (!30 mg/g), data that were not determined in the present study.
The WHR is also a variable that can explain the fact that the percentage of women classified as having MS was higher according to the IDF criterion, which has a cut-off point of 80 cm for women for the definition of abdominal adiposity, as opposed to the cut-off point of 88 cm according to the NCEP. On the basis of this difference in the cut-off points between the NCEP and IDF, 13 (19.4%) patients considered to have increased adiposity based on WC according to the IDF no longer showed this increase according to the criterion of the NCEP.
In addition, the advanced age range of the present subjects (mean ± SD: 58.9 ± 12.3 years) may have contributed to higher WC values since aging involves a physiological process accompanied by progressive changes in body composition. For this reason, changes in the quantity and distribution of body tissue were expected, mainly as demonstrated by an important reduction of muscle tissue in parallel to an increase in adipose tissue, mainly visceral, localized in the abdominal region [40] .
An interesting finding in this study is that glucose correlates with the great majority of the parameters, however, it is possible to highlight its correlation with BMI and WC since these have relation with possible health implications such as insulin resistance, Table 5 Correlation of anthropometric and body composition measurements with biochemical parameters in breast cancer patients (n ¼ 67).
Variables
Biochemical parameters À0.035 À0.056 À0.006 À0.043 0.020 FFM (%) À0.026 À0.191 0.006 0.099 0.244* BMI-body mass index; ACe arm circumference; FM e fat mass; FFM e fat-free mass. * Significant correlation at p < 0.05. **Significant correlation at p < 0.01. Fig. 1 . Prevalence of women with breast cancer with or without metabolic syndrome according to WHO, IDF and NCEP III criteria.
abdominal fat storage and consequently the metabolic syndrome. Gathirua-Mwangi et al. (2018) evaluated women in a cohort from NHANHES III and found that MS is associated with total-cancer and breast-cancer mortality, with waist circumference, blood pressure and blood glucose as independent predictors of obesity-linkedcancers and breast cancer mortality, reinforcing the findings of this study and demonstrating the importance of the monitoring of the glycidic profile and possible MS in these patients [41] .
Conclusion
In conclusion, whereas a high prevalence of excess weight and MS was observed, malnutrition was present in a minority of the participants. We recommend that the nutritional and metabolic status of these patients be routinely assessed in view of the possibility of nutritional and metabolic imbalances that may have a relevant impact on the results of treatment of patients with breast cancer. Among the criteria used to define MS, the one suggested by the IDF seemed to be the most appropriate for the present patients. Prospective studies are necessary to determine whether the criteria currently used to define MS can correctly identify women at higher risk for an unfavorable outcome.
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